HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer.
Moliterni A, Ménard S, Valagussa P, Biganzoli E, Boracchi P, Balsari A, Casalini P, Tomasic G, Marubini E, Pilotti S, Bonadonna G.
Moliterni A, et al. Among authors: valagussa p.
J Clin Oncol. 2003 Feb 1;21(3):458-62. doi: 10.1200/JCO.2003.04.021.
J Clin Oncol. 2003.
PMID: 12560435
Clinical Trial.